UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232

2023

Volltextzugriff (PDF)

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications

JAMA : the journal of the American Medical Association, 2024-07, Vol.332 (2), p.171

Hobai, Ion A

2024

Volltextzugriff (PDF)

GLP-1 Agonists for Obesity

JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (8), p.672

2024

Volltextzugriff (PDF)

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications

JAMA : the journal of the American Medical Association, 2024-07, Vol.332 (2), p.171

Levi, Marc

2024

Volltextzugriff (PDF)

Trial of Lixisenatide in Early Parkinson’s Disease

The New England journal of medicine, 2024-04, Vol.390 (13), p.1176-1185

2024

Volltextzugriff (PDF)

GLP-1 Agonists for Obesity

JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (8), p.674

Langland, James T

2024

Volltextzugriff (PDF)

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists. Reply

The New England journal of medicine, 2024-08, Vol.391 (8), p.776

2024

Volltextzugriff (PDF)

The benefits of GLP-1 drugs beyond obesity

Science (American Association for the Advancement of Science), 2024-07, Vol.385 (6706), p.258-260

Drucker, Daniel J

2024

Volltextzugriff (PDF)

Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?

JAMA : the journal of the American Medical Association, 2024-05, Vol.331 (18), p.1519

Rubin, Rita

2024

Volltextzugriff (PDF)

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

The New England journal of medicine, 2024-08, Vol.391 (8), p.775

2024

Volltextzugriff (PDF)

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

The New England journal of medicine, 2024-05, Vol.390 (20), p.1839-1842

2024

Volltextzugriff (PDF)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

The New England journal of medicine, 2024-07, Vol.391 (2), p.109-121

2024

Volltextzugriff (PDF)

Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis

European neuropsychopharmacology, 2024-05, Vol.82, p.82-91

2024

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas

Expert opinion on drug safety, 2024-05, Vol.23 (5), p.539-542

McIntyre, Roger S

2024

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

Diabetologia, 2024-03, Vol.67 (3), p.561-566

2024

Volltextzugriff (PDF)

Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials

Cardiovascular drugs and therapy, 2024-04, Vol.38 (2), p.371-389

2024

Volltextzugriff (PDF)

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

The New England journal of medicine, 2024-08, Vol.391 (8), p.775

2024

Volltextzugriff (PDF)

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

Diabetes care, 2023-02, Vol.46 (2), p.384-390

2023

Volltextzugriff (PDF)

Effectiveness and safety of the combination of sodium-glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Cardiovascular diabetology, 2024-03, Vol.23 (1), p.99-22, Article 99

2024

Volltextzugriff (PDF)

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis

BMJ (Online), 2024-01, Vol.384, p.e076410

2024

Volltextzugriff (PDF)

GLP-1 receptor agonists for the treatment of patients with heart failure? : STEP-HFpEF and STEP-HFpEF DM

Innere Medizin (Heidelberg, Germany), 2024-10, Vol.65 (10), p.1044

2024

Volltextzugriff (PDF)

Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations"

The journal of ECT, 2024-09, Vol.40 (3), p.219-220

Jacobi, David

2024

Volltextzugriff (PDF)

Association between Glucagon-like Peptide-1 Receptor Agonists and Aspiration Pneumonia during Endoscopic Procedures

Anesthesiology (Philadelphia), 2024-11, Vol.141 (5), p.1009-1012

2024

Volltextzugriff (PDF)

Preoperative continuation of GLP-1 receptor agonists. Response to Br J Anaesth 2024; 133: 437–8

British journal of anaesthesia : BJA, 2024-10, Vol.133 (4), p.882-883

2024

Volltextzugriff (PDF)

Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report

Canadian journal of anesthesia, 2023-08, Vol.70 (8), p.1397-1400

2023

Volltextzugriff (PDF)

1 – 25 von 3.633

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.191)
Mit Volltextzugriff
(2.905)

Publikationsform

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.210)
Life Sciences & Biomedicine
(3.110)
Humans
(2.580)
Glucagon-Like Peptide-1 Receptor - Agonists
(1.924)
Diabetes Mellitus, Type 2 - Drug Therapy
(1.760)
Endocrinology & Metabolism
(1.336)
Diabetes
(1.312)
Hypoglycemic Agents - Therapeutic Use
(1.293)
Glucagon
(1.134)
Male
(1.057)
Animals
(1.045)
Diabetes Mellitus
(928)
Glucagon-Like Peptide-1 Receptor
(863)
Type 2 Diabetes
(824)
Female
(733)
Peptides
(718)
Receptors, Glucagon - Agonists
(689)
Glucagon-Like Peptide 1
(688)
Pharmacology & Pharmacy
(640)
Glucagon-Like Peptide-1 Receptor Agonists
(622)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications

GLP-1 Agonists for Obesity

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications

Trial of Lixisenatide in Early Parkinson’s Disease

GLP-1 Agonists for Obesity

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists. Reply

The benefits of GLP-1 drugs beyond obesity

Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas

Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials

Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

Effectiveness and safety of the combination of sodium-glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis

GLP-1 receptor agonists for the treatment of patients with heart failure? : STEP-HFpEF and STEP-HFpEF DM

Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations"

Association between Glucagon-like Peptide-1 Receptor Agonists and Aspiration Pneumonia during Endoscopic Procedures

Preoperative continuation of GLP-1 receptor agonists. Response to Br J Anaesth 2024; 133: 437–8

Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report

Suchergebnisse filtern